Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV2V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $117,600
Award facts
- Contract value 100% obligated
- $117,599.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $117,599.88 for Gemtesa 75 mg tablets (90-count packages). The contract was awarded on January 26, 2026, with an ultimate completion date of January 27, 2026, utilizing firm fixed-price pricing with no set-aside designation. This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 vehicle that extends through December 2031 and serves as the primary mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
The Gemtesa procurement supports military medical supply chain operations by delivering a bladder control medication used in the treatment of overactive bladder. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the federal pharmaceutical distribution network, competing on a full and open basis against other qualified suppliers. The DLA Troop Support Medical contract vehicle enables efficient fulfillment of diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FQV2V?
SPE2DR26FQV2V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FQV2V worth?
The government has obligated $117,600 on SPE2DR26FQV2V.
Is contract SPE2DR26FQV2V an order under another contract?
Yes. SPE2DR26FQV2V is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV2V competed?
The extent of competition for SPE2DR26FQV2V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award